Autoimmune Disease Drug Market, Global Outlook and Forecast 2023-2029

Report ID: MMG175104 | Category: Pharma & Healthcare | Pages: 67 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Autoimmune disease is a condition in which the immune system is unable to recognize the body’s own cells and starts attacking them. The immune system might attack different types of body cells, depending on which the autoimmune disease is classified. This disease might result in degradation as well as improper functioning of body organs.
This report aims to provide a comprehensive presentation of the global market for Autoimmune Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Disease Drug. This report contains market size and forecasts of Autoimmune Disease Drug in global, including the following market information:
Global Autoimmune Disease Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Autoimmune Disease Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
NSAIDs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Autoimmune Disease Drug include Abbott Laboratories, Pfizer, AbbVie, Eli Lilly, Bristol-Myers Squibb, AstraZeneca plc, GlaxoSmithKline, Roche and Biogen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Autoimmune Disease Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autoimmune Disease Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Autoimmune Disease Drug Market Segment Percentages, by Type, 2022 (%)
    NSAIDs
    Anti-Inflammatory
    Interferons
    Antihyperglycemics
    Others
Global Autoimmune Disease Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Autoimmune Disease Drug Market Segment Percentages, by Application, 2022 (%)
    Rheumatoid Arthritis
    Type 1 Diabetes
    Multiple Sclerosis
    Psoriasis
    Lupus
    Inflammatory Bowel Disease
    Others
Global Autoimmune Disease Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Autoimmune Disease Drug Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autoimmune Disease Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Autoimmune Disease Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Abbott Laboratories
    Pfizer
    AbbVie
    Eli Lilly
    Bristol-Myers Squibb
    AstraZeneca plc
    GlaxoSmithKline
    Roche
    Biogen
    Amgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Autoimmune Disease Drug, market overview.
Chapter 2: Global Autoimmune Disease Drug market size in revenue.
Chapter 3: Detailed analysis of Autoimmune Disease Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Autoimmune Disease Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Autoimmune Disease Drug Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Autoimmune Disease Drug Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Autoimmune Disease Drug Overall Market Size
    2.1 Global Autoimmune Disease Drug Market Size: 2022 VS 2029
    2.2 Global Autoimmune Disease Drug Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Autoimmune Disease Drug Players in Global Market
    3.2 Top Global Autoimmune Disease Drug Companies Ranked by Revenue
    3.3 Global Autoimmune Disease Drug Revenue by Companies
    3.4 Top 3 and Top 5 Autoimmune Disease Drug Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Autoimmune Disease Drug Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Autoimmune Disease Drug Players in Global Market
        3.6.1 List of Global Tier 1 Autoimmune Disease Drug Companies
        3.6.2 List of Global Tier 2 and Tier 3 Autoimmune Disease Drug Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Autoimmune Disease Drug Market Size Markets, 2022 & 2029
        4.1.2 NSAIDs
        4.1.3 Anti-Inflammatory
        4.1.4 Interferons
        4.1.5 Antihyperglycemics
        4.1.6 Others
    4.2 By Type - Global Autoimmune Disease Drug Revenue & Forecasts
        4.2.1 By Type - Global Autoimmune Disease Drug Revenue, 2018-2023
        4.2.2 By Type - Global Autoimmune Disease Drug Revenue, 2024-2029
        4.2.3 By Type - Global Autoimmune Disease Drug Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Autoimmune Disease Drug Market Size, 2022 & 2029
        5.1.2 Rheumatoid Arthritis
        5.1.3 Type 1 Diabetes
        5.1.4 Multiple Sclerosis
        5.1.5 Psoriasis
        5.1.6 Lupus
        5.1.7 Inflammatory Bowel Disease
        5.1.8 Others
    5.2 By Application - Global Autoimmune Disease Drug Revenue & Forecasts
        5.2.1 By Application - Global Autoimmune Disease Drug Revenue, 2018-2023
        5.2.2 By Application - Global Autoimmune Disease Drug Revenue, 2024-2029
        5.2.3 By Application - Global Autoimmune Disease Drug Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Autoimmune Disease Drug Market Size, 2022 & 2029
    6.2 By Region - Global Autoimmune Disease Drug Revenue & Forecasts
        6.2.1 By Region - Global Autoimmune Disease Drug Revenue, 2018-2023
        6.2.2 By Region - Global Autoimmune Disease Drug Revenue, 2024-2029
        6.2.3 By Region - Global Autoimmune Disease Drug Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Autoimmune Disease Drug Revenue, 2018-2029
        6.3.2 US Autoimmune Disease Drug Market Size, 2018-2029
        6.3.3 Canada Autoimmune Disease Drug Market Size, 2018-2029
        6.3.4 Mexico Autoimmune Disease Drug Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Autoimmune Disease Drug Revenue, 2018-2029
        6.4.2 Germany Autoimmune Disease Drug Market Size, 2018-2029
        6.4.3 France Autoimmune Disease Drug Market Size, 2018-2029
        6.4.4 U.K. Autoimmune Disease Drug Market Size, 2018-2029
        6.4.5 Italy Autoimmune Disease Drug Market Size, 2018-2029
        6.4.6 Russia Autoimmune Disease Drug Market Size, 2018-2029
        6.4.7 Nordic Countries Autoimmune Disease Drug Market Size, 2018-2029
        6.4.8 Benelux Autoimmune Disease Drug Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Autoimmune Disease Drug Revenue, 2018-2029
        6.5.2 China Autoimmune Disease Drug Market Size, 2018-2029
        6.5.3 Japan Autoimmune Disease Drug Market Size, 2018-2029
        6.5.4 South Korea Autoimmune Disease Drug Market Size, 2018-2029
        6.5.5 Southeast Asia Autoimmune Disease Drug Market Size, 2018-2029
        6.5.6 India Autoimmune Disease Drug Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Autoimmune Disease Drug Revenue, 2018-2029
        6.6.2 Brazil Autoimmune Disease Drug Market Size, 2018-2029
        6.6.3 Argentina Autoimmune Disease Drug Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Autoimmune Disease Drug Revenue, 2018-2029
        6.7.2 Turkey Autoimmune Disease Drug Market Size, 2018-2029
        6.7.3 Israel Autoimmune Disease Drug Market Size, 2018-2029
        6.7.4 Saudi Arabia Autoimmune Disease Drug Market Size, 2018-2029
        6.7.5 UAE Autoimmune Disease Drug Market Size, 2018-2029
7 Autoimmune Disease Drug Companies Profiles
    7.1 Abbott Laboratories
        7.1.1 Abbott Laboratories Company Summary
        7.1.2 Abbott Laboratories Business Overview
        7.1.3 Abbott Laboratories Autoimmune Disease Drug Major Product Offerings
        7.1.4 Abbott Laboratories Autoimmune Disease Drug Revenue in Global Market (2018-2023)
        7.1.5 Abbott Laboratories Key News & Latest Developments
    7.2 Pfizer
        7.2.1 Pfizer Company Summary
        7.2.2 Pfizer Business Overview
        7.2.3 Pfizer Autoimmune Disease Drug Major Product Offerings
        7.2.4 Pfizer Autoimmune Disease Drug Revenue in Global Market (2018-2023)
        7.2.5 Pfizer Key News & Latest Developments
    7.3 AbbVie
        7.3.1 AbbVie Company Summary
        7.3.2 AbbVie Business Overview
        7.3.3 AbbVie Autoimmune Disease Drug Major Product Offerings
        7.3.4 AbbVie Autoimmune Disease Drug Revenue in Global Market (2018-2023)
        7.3.5 AbbVie Key News & Latest Developments
    7.4 Eli Lilly
        7.4.1 Eli Lilly Company Summary
        7.4.2 Eli Lilly Business Overview
        7.4.3 Eli Lilly Autoimmune Disease Drug Major Product Offerings
        7.4.4 Eli Lilly Autoimmune Disease Drug Revenue in Global Market (2018-2023)
        7.4.5 Eli Lilly Key News & Latest Developments
    7.5 Bristol-Myers Squibb
        7.5.1 Bristol-Myers Squibb Company Summary
        7.5.2 Bristol-Myers Squibb Business Overview
        7.5.3 Bristol-Myers Squibb Autoimmune Disease Drug Major Product Offerings
        7.5.4 Bristol-Myers Squibb Autoimmune Disease Drug Revenue in Global Market (2018-2023)
        7.5.5 Bristol-Myers Squibb Key News & Latest Developments
    7.6 AstraZeneca plc
        7.6.1 AstraZeneca plc Company Summary
        7.6.2 AstraZeneca plc Business Overview
        7.6.3 AstraZeneca plc Autoimmune Disease Drug Major Product Offerings
        7.6.4 AstraZeneca plc Autoimmune Disease Drug Revenue in Global Market (2018-2023)
        7.6.5 AstraZeneca plc Key News & Latest Developments
    7.7 GlaxoSmithKline
        7.7.1 GlaxoSmithKline Company Summary
        7.7.2 GlaxoSmithKline Business Overview
        7.7.3 GlaxoSmithKline Autoimmune Disease Drug Major Product Offerings
        7.7.4 GlaxoSmithKline Autoimmune Disease Drug Revenue in Global Market (2018-2023)
        7.7.5 GlaxoSmithKline Key News & Latest Developments
    7.8 Roche
        7.8.1 Roche Company Summary
        7.8.2 Roche Business Overview
        7.8.3 Roche Autoimmune Disease Drug Major Product Offerings
        7.8.4 Roche Autoimmune Disease Drug Revenue in Global Market (2018-2023)
        7.8.5 Roche Key News & Latest Developments
    7.9 Biogen
        7.9.1 Biogen Company Summary
        7.9.2 Biogen Business Overview
        7.9.3 Biogen Autoimmune Disease Drug Major Product Offerings
        7.9.4 Biogen Autoimmune Disease Drug Revenue in Global Market (2018-2023)
        7.9.5 Biogen Key News & Latest Developments
    7.10 Amgen
        7.10.1 Amgen Company Summary
        7.10.2 Amgen Business Overview
        7.10.3 Amgen Autoimmune Disease Drug Major Product Offerings
        7.10.4 Amgen Autoimmune Disease Drug Revenue in Global Market (2018-2023)
        7.10.5 Amgen Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Autoimmune Disease Drug Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?